title: Design, synthesis and pharmacological characterization of a potent radioiodinated and photoactivatable peptidic oxytocin antagonist.
abstract: Using a segment strategy, we have synthesized four iodinated photoactivatable cyclic peptidic ligands of oxytocin, bearing a beta-mercapto-betabeta-cyclopentamethylene propionic group (Pmp) on their N-terminus. All the syntheses were RP-HPLC monitored, and the compounds were HPLC purified. They were characterized by 1H NMR, MALDI-TOF, or FAB mass spectrometries. The affinities of Pmp-Tyr(Me)-Ile-Thr-Asn-Cys-Gly-Orn-Phe(3I,4N3)-NH2 (20), Pmp-Tyr-Ile-Thr-Asn-Cys-Gly-Orn-Phe(3I,4N3)-NH2 (21), Pmp-Tyr(Me)-Ile-Thr-Asn-Cys-Pro-Orn-Phe(3I,4N3)-NH2 (22), and Pmp-Tyr-Ile-Thr-Asn-Cys-Pro-Orn-Phe(3I,4N3)-NH2 (23) were evaluated as inhibition constants (K(i), in nM) for the human oxytocin receptor expressed in Chinese hamster ovary cells by displacement of a radioiodinated disulfide-cyclized antagonist (Elands et al. Eur. J. Pharmacol. 1987, 147, 197-207). The most potent of them, compound 22, was synthesized by another method in order to allow its radiolabeling by 125I. Its dissociation constant (K(d)) for the human oxytocin receptor, directly measured in saturation studies, was 0.25 +/- 0.04 nM, and its antagonist properties were determined by inactivation of phospholipase C, thus obtaining an inactivation constant (K(inact)) of 0.18 +/- 0.02 nM, evaluated by inositol phosphate accumulation. This compound is a very good tool for the mapping of peptidic antagonist binding sites in the human oxytocin receptor.
authors.affiliation: CNRS UPR 9023 and INSERM U 469, CCIPE, 141, rue de la Cardonille, 34094 Montpellier Cedex 5, France. carnazzi@colombes.pharma.univ-montp1.fr
authors.forename: E
authors.initials: E
authors.lastname: Carnazzi
authors.forename: A
authors.initials: A
authors.lastname: Aumelas
authors.forename: B
authors.initials: B
authors.lastname: Mouillac
authors.forename: C
authors.initials: C
authors.lastname: Breton
authors.forename: L
authors.initials: L
authors.lastname: Guillou
authors.forename: C
authors.initials: C
authors.lastname: Barberis
authors.forename: R
authors.initials: R
authors.lastname: Seyer
mesh_terms: D000818:Animals; D001667:Binding, Competitive; D016466:CHO Cells; D002851:Chromatography, High Pressure Liquid; D006224:Cricetinae; D015195:Drug Design; D006801:Humans; D066298:In Vitro Techniques; D007295:Inositol Phosphates / Q000096:biosynthesis; D007457:Iodine Radioisotopes; D009682:Magnetic Resonance Spectroscopy; D010456:Peptides, Cyclic / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology; D010782:Photolysis; D011869:Radioligand Assay; D018045:Receptors, Oxytocin / Q000037:antagonists & inhibitors*; D016339:Spectrometry, Mass, Fast Atom Bombardment; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; D013329:Structure-Activity Relationship
chemical_list: D007295:Inositol Phosphates; D007457:Iodine Radioisotopes; D010456:Peptides, Cyclic; D018045:Receptors, Oxytocin